Byung Ik Park
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Byung Ik Park has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Jeong-Yun Sun
Seoul National University
3 shared publications - Dong‐Yup Lee
Department of Materials Science and Engineering Seoul National University Seoul Republic of Korea
2 shared publications - Min-Gyu Lee
Department of Materials Science and Engineering, Seoul National University, Seoul 08826, South Korea
2 shared publications - Yong Eun Cho
Departmant of Materials Science and Engineering Seoul National University Seoul 08826 Republic of Korea
2 shared publications - Yun Hyeok Lee
Departmant of Materials Science and Engineering Seoul National University Seoul 08826 Republic of Korea
2 shared publications Chang Seo Park
Departmant of Materials Science and Engineering Seoul National University Seoul 08826 Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 17 July 2026
- Published by Wiley in Advanced Functional Materials
- p. e76901
Implantable Ionic Memristors Based on Natural Polymer Heterojunctions
Memristors emulate the synaptic plasticity of the human brain by exhibiting conductance modulation dependent on prior stimuli, thereby enabling simultaneous information processing and storage. Ionic memristors, which utilize the migration of biological ions (e.g., K + , Cl − ), exhibit history‐dependent synaptic plasticity and offer a more biocompatible approach than conventional solid‐state electronic memristors. However, existing ionic memristors typically employ rigid substrates and biologically incompatible materials, which limit their potential for use in implantable devices. Here, we report a fully biocompatible natural polymer‐based ionic memristor, comprising a hyaluronic acid hydrogel, a chitosan hydrogel, and a polydimethylsiloxane (PDMS) substrate. Hyaluronic acid and chitosan are biodegradable natural polymers widely used in biomedical applications, while PDMS is a biocompatible elastomer demonstrating safety. Furthermore, our memristor operates as a dynamic memristor capable of performing reservoir computing. The reservoir computing implemented via our memristor achieved a prediction accuracy of 98.94%, while reducing the training time by 36.8% compared to systems that do not incorporate the memristors. Notably, the device maintained its computational performance post‐implantation and demonstrated excellent biocompatibility in both in vitro and in vivo evaluations. Collectively, these results highlight the potential of our approach as an implantable platform for bio‐integrated computing and next‐generation biomedical engineering.
- 17 July 2026
- Published by Wiley in Advanced Functional Materials
- p. e76901
Open AccessImplantable Ionic Memristors Based on Natural Polymer Heterojunctions
Memristors emulate the synaptic plasticity of the human brain by exhibiting conductance modulation dependent on prior stimuli, thereby enabling simultaneous information processing and storage. Ionic memristors, which utilize the migration of biological ions (e.g., K + , Cl − ), exhibit history‐dependent synaptic plasticity and offer a more biocompatible approach than conventional solid‐state electronic memristors. However, existing ionic memristors typically employ rigid substrates and biologically incompatible materials, which limit their potential for use in implantable devices. Here, we report a fully biocompatible natural polymer‐based ionic memristor, comprising a hyaluronic acid hydrogel, a chitosan hydrogel, and a polydimethylsiloxane (PDMS) substrate. Hyaluronic acid and chitosan are biodegradable natural polymers widely used in biomedical applications, while PDMS is a biocompatible elastomer demonstrating safety. Furthermore, our memristor operates as a dynamic memristor capable of performing reservoir computing. The reservoir computing implemented via our memristor achieved a prediction accuracy of 98.94%, while reducing the training time by 36.8% compared to systems that do not incorporate the memristors. Notably, the device maintained its computational performance post‐implantation and demonstrated excellent biocompatibility in both in vitro and in vivo evaluations. Collectively, these results highlight the potential of our approach as an implantable platform for bio‐integrated computing and next‐generation biomedical engineering.
- Open Access
- 20 March 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (12) , eaeb7409
A reconfigurable dielectric elastomer actuator via phase-transitional ferrofluid enables sustainable operation
Dielectric elastomer actuators (DEAs) are promising soft transducers capable of rapid and precise actuation. However, their conventional architecture for efficient actuation confines DEAs in predesigned operational modes, leading to limited applications. Here, we introduce a reconfigurable DEA system using phase-transitional ferrofluid (PTF) electrodes. PTF switches its states between solid and liquid, satisfying requirements for a reconfigurable electrode for DEAs. In the sol state, the stable and high magnetic responsiveness inspired by ferrofluid and the low viscosity achieved through plasticization collectively enable dynamic reconfiguration of the electrode. In the gel state, PTF ensures stable shape retention and exhibits reduced interfacial slip during DEA actuation. This reconfigurable nature greatly increases adaptability and ensures continuous operation even when electrodes undergo disconnection or dielectric failure. Moreover, the PTF electrodes can be retrieved and reused after actuation, demonstrating their excellent recyclability. The combination of mechanical compliance, magnetic reconfigurability, and material sustainability renders the PTF a versatile electrode strategy for next-generation reconfigurable electroactive systems.
- 20 March 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (12) , eaeb7409
Open AccessA reconfigurable dielectric elastomer actuator via phase-transitional ferrofluid enables sustainable operation
Dielectric elastomer actuators (DEAs) are promising soft transducers capable of rapid and precise actuation. However, their conventional architecture for efficient actuation confines DEAs in predesigned operational modes, leading to limited applications. Here, we introduce a reconfigurable DEA system using phase-transitional ferrofluid (PTF) electrodes. PTF switches its states between solid and liquid, satisfying requirements for a reconfigurable electrode for DEAs. In the sol state, the stable and high magnetic responsiveness inspired by ferrofluid and the low viscosity achieved through plasticization collectively enable dynamic reconfiguration of the electrode. In the gel state, PTF ensures stable shape retention and exhibits reduced interfacial slip during DEA actuation. This reconfigurable nature greatly increases adaptability and ensures continuous operation even when electrodes undergo disconnection or dielectric failure. Moreover, the PTF electrodes can be retrieved and reused after actuation, demonstrating their excellent recyclability. The combination of mechanical compliance, magnetic reconfigurability, and material sustainability renders the PTF a versatile electrode strategy for next-generation reconfigurable electroactive systems.
- Open Access
- 22 August 2025
- Published by Wiley in Advanced Functional Materials
- Vol. 36 (9)
Enzyme‐Regulated Extended Swelling of Hydrogels for Dehiscence‐Less Tissue Expansions
Tissue expansion is traditionally achieved by injecting saline into an implanted silicone balloon via external tubing, which causes patient discomfort. Hydrogels eliminate the need for tubing due to their self‐swelling properties, but they fail to prevent suture wound dehiscence due to immediate swelling after implantation. Here, the concept of “extended swelling” in an interpenetrating hydrogel network is introduced to avoid dehiscence. The hydrogel consists of enzymatically degradable hyaluronic acid (HA) networks and non‐degradable polyacrylic acid (PAAc) networks. The gel remains structurally intact until suture wound healing after implantation by the constraint of the HA networks on the PAAc networks. Upon hyaluronidase (HYAL) injection, the HA networks degrade, initiating the extended swelling after which enzymatic degradation controls its onset and rate. Furthermore, the generalized ideal elastomeric gel model is employed to understand the extended swelling process. The model predicts the maximum extended equilibrium swelling ratio in vivo, confirming the hydrogel's ability to generate sufficient pressure while preventing overexpansion beyond the tissue rupture threshold. The theoretical framework aligns with experimental observations, demonstrating that the tissue expansion is induced by yes1‐associated protein (YAP1)‐mediated epidermal proliferation. This approach establishes its potential as a next‐generation tissue expander for clinical applications.
- 22 August 2025
- Published by Wiley in Advanced Functional Materials
- Vol. 36 (9)
Open AccessEnzyme‐Regulated Extended Swelling of Hydrogels for Dehiscence‐Less Tissue Expansions
Tissue expansion is traditionally achieved by injecting saline into an implanted silicone balloon via external tubing, which causes patient discomfort. Hydrogels eliminate the need for tubing due to their self‐swelling properties, but they fail to prevent suture wound dehiscence due to immediate swelling after implantation. Here, the concept of “extended swelling” in an interpenetrating hydrogel network is introduced to avoid dehiscence. The hydrogel consists of enzymatically degradable hyaluronic acid (HA) networks and non‐degradable polyacrylic acid (PAAc) networks. The gel remains structurally intact until suture wound healing after implantation by the constraint of the HA networks on the PAAc networks. Upon hyaluronidase (HYAL) injection, the HA networks degrade, initiating the extended swelling after which enzymatic degradation controls its onset and rate. Furthermore, the generalized ideal elastomeric gel model is employed to understand the extended swelling process. The model predicts the maximum extended equilibrium swelling ratio in vivo, confirming the hydrogel's ability to generate sufficient pressure while preventing overexpansion beyond the tissue rupture threshold. The theoretical framework aligns with experimental observations, demonstrating that the tissue expansion is induced by yes1‐associated protein (YAP1)‐mediated epidermal proliferation. This approach establishes its potential as a next‐generation tissue expander for clinical applications.